Key Takeaways

• Shares of UnitedHealth declined more than 5% during Monday’s premarket session following Berkshire Hathaway’s disclosure of a complete exit from its approximately 5 million-share holding
• The divestment comes as part of CEO Greg Abel’s strategic portfolio restructuring following his January 1 takeover from Warren Buffett
• Additional headwinds include a federal moratorium restricting new Medicare enrollments for home health service providers
• Management announced plans to reduce its Medicare Advantage enrollment by 1.3 million members to safeguard profitability amid escalating healthcare costs
• The health insurance giant exceeded first-quarter profit expectations and upgraded its annual earnings guidance in recent financial results

Shares of UnitedHealth (UNH) tumbled over 5% during Monday’s premarket session, falling to approximately $380.35, following Berkshire Hathaway’s disclosure that it had liquidated its complete ownership stake in the healthcare giant.

UnitedHealth Group Incorporated, UNH

The conglomerate’s most recent 13F regulatory filing, which reflects investment positions through March 31, revealed that Berkshire divested its entire holding of roughly 5 million shares in UNH. The exit is particularly striking given that Berkshire had only initiated the position during the second quarter of 2025 — representing a holding period of less than twelve months.

This strategic shift represents part of a comprehensive portfolio realignment orchestrated by Greg Abel, who assumed the chief executive role at Berkshire on January 1, taking the helm from legendary investor Warren Buffett.

When an investor of Berkshire’s caliber exits a position so rapidly, market participants pay attention. The disclosure triggered a wave of selling as investors interpreted the move as a bearish signal.

Berkshire’s divestment activity extended beyond UNH. The investment powerhouse also completely liquidated holdings in Amazon, Domino’s, Pool Corp, Mastercard, and Visa throughout the first quarter. These stocks experienced modest declines in early Monday trading.

Meanwhile, Berkshire initiated new positions in Delta Air Lines and Macy’s, while expanding existing stakes in Alphabet and the New York Times.

Government Restrictions and Strategic Member Cuts Compound Challenges

The selling pressure extends beyond the Berkshire announcement. UNH faces mounting pressure from a federal government moratorium that blocks new Medicare enrollments for home healthcare service providers, introducing significant regulatory uncertainty.

Compounding these challenges, company leadership has announced intentions to slash 1.3 million members from its Medicare Advantage programs. This aggressive reduction represents a calculated approach to preserve profitability in an environment of accelerating medical expense inflation.

The convergence of these factors — a prominent institutional investor exit, mounting regulatory obstacles, and intentional membership contraction — has prompted market participants to recalibrate their expectations for the stock’s near-term trajectory.

Justice Department Investigation Remains an Overhang

UNH continues to operate under Department of Justice scrutiny related to its billing methodologies, an investigation that has lingered for an extended period. This regulatory cloud continues to cast a shadow over the company’s prospects.

Heading into this week, the stock had already declined approximately 20% year-to-date, making Monday’s selloff another difficult development in what has been a challenging period for the managed-care leader.

However, the picture isn’t entirely bleak. UnitedHealth’s first-quarter financial performance demonstrated operational resilience.

The company surpassed Wall Street’s Q1 profit projections and elevated its full-year earnings forecast, developments that had offered some support to the stock before Monday’s Berkshire disclosure.

Technical indicators currently signal a Buy rating for UNH, with average daily trading volume hovering around 8.49 million shares. The company maintains a market capitalization of roughly $357.7 billion.

For the immediate future, the stock faces the challenge of digesting Berkshire’s high-profile exit alongside ongoing concerns surrounding Medicare reimbursement pressures and enrollment dynamics.

Key Takeaways

• SpaceX executed a five-for-one stock split in preparation for its upcoming initial public offering, potentially valuing the company at $2 trillion
• The public offering could generate $75 billion in capital, with investor presentations scheduled for early June
• Elon Musk’s compensation structure includes up to 260 million shares tied to performance milestones, potentially valued at $500 billion
• Special voting rights attached to Musk’s shares will ensure he maintains majority control of the aerospace company
• Stocks across the commercial space industry rallied during Monday’s premarket session after Musk discussed the IPO timeline

Elon Musk’s aerospace venture has completed a five-for-one stock split as it advances toward what may become one of the most significant public offerings in corporate history. Fresh information regarding the company’s ownership structure, executive compensation, and investor implications continues to emerge.

Stock Division and Public Offering Schedule

The aerospace manufacturer implemented a five-for-one share division prior to its anticipated market debut. This adjustment positions the private market valuation at approximately $100 per share. Analysts project the actual IPO pricing could reach closer to $160.

The organization submitted its registration documents confidentially to the Securities and Exchange Commission during late March or early April. Market participants anticipate complete disclosure of these filings within the coming days. Investor presentations are scheduled to commence in early June, with the offering expected to finalize before the end of July.

This public debut could secure $75 billion in funding while establishing a market capitalization approaching $2 trillion. Individual retail investors are projected to constitute a substantial portion of demand, particularly those who already maintain positions in Tesla shares.

Companies typically execute stock splits after becoming publicly traded entities. The decision by SpaceX to implement this division before its IPO represents an uncommon approach. This reduced per-share price point should facilitate access for retail investors with smaller investment budgets.

Executive Compensation Structure and Governance Rights

Musk has opted for zero cash salary. His compensation consists entirely of up to 260 million shares contingent upon achieving defined milestones. These objectives encompass expanding SpaceX’s valuation to $7.5 trillion, establishing human settlements on Mars, and deploying artificial intelligence infrastructure in orbital environments.

Should all performance benchmarks be met, this equity compensation could reach approximately $500 billion in value. Combined with his existing holdings, Musk’s total ownership stake could approach $3.5 trillion.

This compensation framework parallels his existing arrangement with Tesla. Tesla’s shareholders previously authorized a package granting Musk over 420 million shares contingent upon expanding that company’s market capitalization to $8.5 trillion.

Musk’s equity holdings will include enhanced voting privileges, ensuring his majority governance authority over SpaceX. He has publicly stated his desire for 25% voting control at Tesla to maintain strategic direction at that organization.

SpaceX representatives did not provide responses to inquiries regarding either the stock division or the compensation arrangement.

Commercial Space Sector Market Response

Equities throughout the commercial space industry experienced upward momentum during Monday’s premarket session following Musk’s public statements about accelerating the IPO process. He delivered these remarks while visiting Texas.

EchoStar shares increased 6.3%. Intuitive Machines surged 5.1%. Rocket Lab climbed 3.4%. AST SpaceMobile appreciated 2%. Viasat advanced 1.4%. York Space Systems rallied 6.5%, while Firefly Aerospace gained 3.9%.

These market movements occurred in anticipation of SpaceX releasing its complete S-1 registration filing with the SEC this week.

Key Takeaways

• Nvidia shares dropped 4.42% to $225.32 on May 15, triggering a broader semiconductor sector decline
• UBS cautioned that 8 of 12 major semiconductor firms represent “extremely crowded long” trades
• TD Cowen boosted NVDA’s price target from $235 to $275, pointing to a $1 trillion+ Blackwell and Rubin order backlog
• Bank of America increased its price target to $320 while Wells Fargo lifted its forecast to $315, maintaining positive outlooks
• Nvidia’s Q1 FY2027 results arrive Wednesday, May 20 — market participants seek confirmation of sustained Blackwell momentum

With Wednesday’s quarterly report looming, Nvidia finds itself navigating increased selling pressure, with shares retreating 4.42% to $225.32 as of May 15. However, the pullback hasn’t dampened Wall Street’s enthusiasm.

NVIDIA Corporation, NVDA

The decline wasn’t isolated to Nvidia alone. A widespread semiconductor sector retreat saw Micron plunge 6.62%, Intel slide 6.18%, AMD decrease 5.69%, Broadcom fall 3.32%, and Marvell decline 3.12%.

Nevertheless, these equities have experienced remarkable rallies. From March 30 forward, Intel rocketed 164% higher, Micron climbed 125%, AMD advanced 116%, Marvell gained 101%, and Nvidia itself appreciated 36%. Such momentum virtually guaranteed eventual profit-taking.

UBS highlighted positioning concerns in a recent research note. Their examination revealed 8 of the 12 largest global semiconductor firms by market capitalization represent extremely crowded long positions. The firm also cautioned that as cloud hyperscalers transition from asset-light to asset-heavy infrastructure models, cash flow return on investment may deteriorate throughout the next three years.

They specifically referenced Nvidia’s CFROI, projected to reach 82% this year. The risk: historically, merely 0.09% of worldwide equities have maintained returns exceeding 50% for five consecutive years, and only 0.02% for ten years.

Wall Street Maintains Optimistic Stance Heading Into Results

Despite UBS’s reservations, most prominent analysts continue supporting Nvidia.

TD Cowen’s Joshua Buchalter — positioned 69th among 12,243 Wall Street analysts with a 72% accuracy rate — elevated his price objective to $275 from $235. He highlighted that Nvidia’s leadership team estimates its combined Blackwell and Rubin order pipeline surpassing $1 trillion, representing potential upside beyond current consensus forecasts. He anticipates Nvidia will exceed quarterly revenue guidance by $1 billion to $2 billion.

Bank of America’s Vivek Arya, ranked 80th with a 65% accuracy rate, increased his target to $320 from $300, maintaining Nvidia as his preferred sector selection. His projection employs a 28x price-to-earnings multiple applied to his 2027 forecast, falling within Nvidia’s historical forward P/E corridor of 25 to 56. BofA also projects the AI data-center marketplace potentially expanding to $1.7 trillion by 2030.

Wells Fargo elevated its target to $315 from $265.

The Post-Earnings Decline Pattern

Here’s the peculiar situation Nvidia confronts: shares frequently decline even following impressive earnings performances.

CEO Jensen Huang acknowledged this phenomenon directly following Q3 FY2026 results. “If we delivered a bad quarter, it is evidence there’s an AI bubble. If we delivered a great quarter, we are fueling the AI bubble.” It creates an impossible narrative framework that complicates sentiment management.

Deutsche Bank’s Ross Seymore recently cautioned that Nvidia’s anticipated growth throughout the coming two years seemingly already factors into current valuations, complicating the delivery of meaningful positive surprises.

Nvidia’s most recent quarterly disclosure demonstrated record revenue reaching $68.1 billion accompanied by a non-GAAP gross margin of 75.2%.

BofA’s identified downside scenarios include gaming sector weakness, custom silicon competition, China export limitations, irregular enterprise purchasing patterns, and heightened regulatory oversight.

All attention turns to Wednesday.

Hyperliquid price stabilized over the weekend after reclaiming a key bullish chart structure, while growing institutional adoption narratives continued supporting investor sentiment around the decentralized derivatives protocol.

According to data from crypto.news, Hyperliquid (HYPE) price was trading around $45 at press time on May 18 after briefly rallying above the $46 level earlier in the session. The token has now recovered more than 100% from its January lows near $22 as demand surrounding decentralized perpetual trading infrastructure continued strengthening.

Despite the recent recovery, Hyperliquid faced heightened volatility over the past two weeks following reports that CME Group and Intercontinental Exchange urged U.S. regulators to scrutinize the protocol over potential market manipulation and sanctions compliance risks.

The concerns reportedly centered around the growing influence of decentralized offshore trading platforms within the perpetual futures market and whether existing compliance frameworks remain sufficient as trading volumes continue expanding rapidly.

The regulatory scrutiny narrative contributed to a sharp correction in Hyperliquid price earlier this month as some traders reduced exposure amid fears that increased oversight could temporarily weigh on sentiment surrounding decentralized derivatives platforms.

However, bulls have since regained control as institutional demand for Hyperliquid-linked investment products continued to accelerate.

One of the biggest catalysts supporting sentiment remains the recent launch of multiple Hyperliquid-related exchange-traded products in the United States.

Earlier this month, Bitwise launched its spot Hyperliquid ETF product, while 21Shares introduced both a spot-focused HYPE ETF and a leveraged 2x Long HYPE ETF. The launches reinforced expectations that institutional appetite for decentralized finance infrastructure continues expanding beyond Bitcoin and Ethereum.

Hyperliquid has also continued benefiting from broader ecosystem integration narratives involving Coinbase and Circle, particularly as institutional stablecoin infrastructure and trading connectivity tied to the protocol keep improving.

At the same time, derivatives activity surrounding Hyperliquid has remained elevated as traders continue positioning for a potential continuation of the broader uptrend.

Hyperliquid price analysis

On the daily chart, Hyperliquid price appears to have reentered a bullish ascending wedge pattern after successfully rebounding from the lower support trendline near the $38–$40 region.

The recovery back toward the upper half of the structure suggests buyers continue defending the broader bullish trend despite recent regulatory-driven volatility.

Unlike the previously invalidated bearish double top structure near the $45–$46 resistance zone, the current setup increasingly resembles a bullish continuation pattern following Hyperliquid’s explosive rally earlier this year.

The MACD indicator has also started turning higher again after a brief cooldown phase, with the histogram gradually flipping back into positive territory. This often signals strengthening bullish momentum as buyers regain short-term control.

Meanwhile, the RSI currently remains near the 58 level, indicating momentum has improved without yet entering overbought territory. That leaves room for another potential leg higher if bullish momentum continues building.

As long as HYPE continues holding above the ascending wedge support near the $40 region, bulls may attempt another breakout above the key $46 resistance zone.

A successful breakout above that level could open the door for a rally toward the psychological $50 mark, with the upper wedge resistance near the $52 region acting as the next major upside target.

On the downside, failure to hold above the wedge support structure could weaken bullish momentum and potentially expose Hyperliquid to another correction toward the $38 support zone. A deeper breakdown below that level could invalidate the broader bullish continuation setup and shift momentum back in favor of sellers.